...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
GSK.L LSE 🇬🇧 UK ISA ✓
GSK plc
Pharmaceuticals
Watch
Price Zone: Buy Zone
🔒 Full AI Analysis — Pro
35Score
DipBuster Score™
£18.50 £0.74 (-3.85%) Live price · Source: Yahoo
52-Week Position
£16.64 30% of range £22.82
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High£22.82
52W Low£16.64
DipBuster Brief Key signals at a glance
Zone: Buy Zone
Neutral
Mid-Range Position (30% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position30% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share—
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts
Loading insider data...

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High£22.82
52W Low£16.64

52-Week Range

£16.64Now£22.82
30% through annual range
From 52W High−19%
From 52W Low+11.1%
📖 Plain English Summary
GSK plc is at 30% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for GSK.L 🟢 Bullish ⬜ Neutral 🔴 Bearish
🇬🇧 View RNS Regulatory Filings on LSE → Official announcements & results
🤖
DipBuster AI Analysis — GSK.L
Heuristic · balance sheet, insider filings, price data, academic research

GSK plc — DipBuster Score 35/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track GSK plc free

Add GSK.L to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Get Started Free →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 28/25
Momentum & Volume 2/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
5 /100 · NEUTRAL
dip depth 5/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 35/100
📉 Weak momentum — price has been struggling lately.

More Pharmaceuticals stocks

LLY Eli Lilly & Co.ABBV AbbVie Inc.MRK Merck & Co.NVO Novo NordiskAMGN Amgen Inc.GILD Gilead SciencesBIIB Biogen Inc.REGN Regeneron PharmaceuticalsAll Pharmaceuticals stocks →